Paper Details

  1. Home
  2. Paper Details

Anti-IL-17 Agents for Psoriasis: A Review of Phase III Data.

Author: AbroukMichael, BeroukhimKourosh, BhutaniTina, FarahnikBenjamin, KooJohn, LeeKristina, NakamuraMio, SinghRasnik, ZhuTian Hao

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This review summarizes the evidence highlighting the vital role of IL-17 in the pathogenesis of psoriasis. Preclinical and Phase II studies focusing on IL-17 and its receptor show promise for treating this disease.
Paper Details　
Original Abstract of the Article :
Studies investigating the molecular basis of psoriasis have established the central roles of TNFa, interleukin (IL)-12, IL-22 and IL-23, and now there is increasing evidence that IL-17 plays a vital role in the complex pathophysiology of this disease. Preclinical and phase II studies of medications ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/26954316

データ提供：米国国立医学図書館（NLM）

Targeting IL-17: A New Oasis in the Desert of Psoriasis

The search for effective treatments for psoriasis is a relentless journey, like navigating a vast and unforgiving desert. This study, published in the field of

dermatology

, delves into the role of interleukin-17 (IL-17) in the complex pathophysiology of psoriasis. The authors review recent research on IL-17 and its potential as a therapeutic target, offering hope for a new approach to treating this debilitating condition.

A Promising New Weapon in the Arsenal

The study highlights the growing evidence supporting IL-17 as a key player in the development of psoriasis. This opens a door for new and more targeted therapies that could be more effective and have fewer side effects than traditional treatments. Like finding a wellspring of water in a parched desert, targeting IL-17 could provide a much-needed solution for patients with psoriasis.

A Brighter Future for Psoriasis Patients

This research offers a glimmer of hope for patients with psoriasis. By focusing on IL-17, researchers are creating a new path to potentially more effective and targeted treatments. This could potentially improve quality of life for those struggling with psoriasis, offering a chance to escape the desert of discomfort and find relief.

Dr. Camel's Conclusion

This study, like a caravan finding an oasis in the desert, suggests that IL-17 may be a key to developing more effective treatments for psoriasis. Targeting this specific protein could lead to more targeted and effective therapies, offering a new path to relief for those struggling with this chronic condition. It's a ray of hope in the desert of psoriasis research.

Date :
  1. Date Completed 2016-12-13
  2. Date Revised 2017-11-16
Further Info :

Pubmed ID

26954316

DOI: Digital Object Identifier

S1545961616P0311X

Related Literature

Article Analysis
・Effects of brodalumab injection
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.